Quantcast

Latest Intravenous immunoglobulin Stories

2009-04-22 13:15:00

18 patient advocacy and health care professional groups join with Congressional sponsors Reps. Israel, Brady and Schwartz to announce new legislation; call for patient access to IVIG WASHINGTON, April 22 /PRNewswire-USNewswire/ -- Members of Congress and patient advocacy groups announced today the introduction of new legislation - H.R. 2002, Medicare Patient IVIG Access Act of 2009 - meant to remedy inadequate Medicare reimbursements that currently restrict patient access to Intravenous...

2009-02-04 10:31:00

SWARTZ CREEK, Mich., Feb. 4 /PRNewswire/ -- Diplomat Specialty Pharmacy is pleased to announce two new "Navigator" initiatives (disease management programs). As of January 2009, DSP launched both a Hemophilia and IVIG Navigator Program. In addition, Scott Reed has joined Diplomat as National Sales Manager for both programs. Reed is a graduate of Indiana University and has over 18 years of pharmaceutical sales experience. Most recently Reed was a Hematology Account Executive with Bayer...

2009-01-24 14:30:47

Scientists at UCSF have discovered an abnormality in a patient's immune system that may lead to safer therapies for autoimmune diseases such as rheumatoid arthritis and colitis, as well as potential new ways to treat transplant rejection. The research identified antibodies from a woman's immune system that prevent infection-fighting T cells from moving through her blood stream and entering her body's organs to attack invaders such as bacteria or viruses. Findings appear in the current online...

2009-01-13 16:37:00

Grifols welcomes Los Angeles Mayor Antonio Villaraigosa, Cal State LA President James Rosser, Councilman Hose Huizar, patient representatives and other dignitaries for the construction dedication ceremony of its new IVIG facility. LOS ANGELES, Jan. 13 /PRNewswire/ -- Today, Grifols SA (Grifols), a global healthcare company based in Barcelona, Spain, Grifols welcomes Los Angeles Mayor Antonio Villaraigosa., Cal State LA President James Rosser, Councilman Jose Huizar and other elected...

2009-01-06 12:09:00

Patients with this Pediatric Disease Depend on Plasma Donation ANNAPOLIS, Md., Jan. 6 /PRNewswire/ --Kawasaki disease is an uncommon illness that typically affects children between the ages of two and five and is a leading cause of acquired heart disease in children in the United States according to the American Heart Association (AHA). Kawasaki disease is treated with intravenous immune globulin (IVIG), a plasma-derived therapy that replaces vital missing antibodies in a person's plasma and...

2008-12-23 14:44:24

Implications for new tests and more personalized treatments for autoimmune diseases More drafts usually mean a better product and so it also seems to go with the human immune system. As B cells develop, genes rearrange to allow their antibodies to recognize different foreign invaders or pathogens. But sometimes antibodies are created that recognize and attack the body's own cells. These self-reactive antibodies, like early drafts of a manuscript, must be edited into safer versions. This...

2008-12-04 10:00:00

ATLANTA and LACHEN, Switzerland, Dec. 4 /PRNewswire/ -- Octapharma Chairman Wolfgang Marguerre today announced that Dennis D. Curtin has been selected to lead Octapharma's plasma operations in the United States. Curtin had been Octapharma's U.S. legal counsel since 2002 and will now serve as President of Life Therapeutics, Inc. The largest private plasma products company in the world, Octapharma recently acquired Life Therapeutics, the Atlanta company that operates 12 plasma centers...

2008-10-27 12:00:10

PROVIDENCE, R.I., Oct. 27 /PRNewswire/ -- Dr. Annie De Groot, CEO of EpiVax, is the lead author on an article highlighting key findings about the activation of natural regulatory T cells by IgG Fc-derived peptide, also known as Epi-13 or "Tregitopes." These findings were published in the October 8 issue of the prestigious Blood, the medical journal published by the American Society of Hematology. In an accompanying editorial, Rachel Caspi of the National Institutes of Health (NIH) wrote,...

2008-10-15 12:00:33

Under a new program introduced by Talecris Biotherapeutics, patients who regularly use Gamunex (Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified) may be able to receive continuing treatment in the event of a lapse in private insurance coverage. Gamunex is an immunoglobulin intravenous (IGIV) therapy that contains antibodies purified from the donated blood plasma of thousands of people. Gamunex is indicated as replacement therapy of primary humoral...

1c523d2e77856dd428c5e894475426621
2008-10-14 11:05:00

Every one in three patients needing a kidney transplant may never receive one because their bodies are unusually conditioned to assault a donated organ. Doctors are now trying to outsmart the immune system and save more "highly sensitized" patients. These patients often have kidneys donated by living donors, thought to be the best kind. "I feel very lucky. Our son saved my life," said Cynthia Preloh, after a curious mixture of blood cleansing and a cancer drug permitted her to accept a...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related